CVKD insider buying and SEC filings, explained
Cadrenal Therapeutics, Inc. · CIK 1937993
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$458K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 29, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 7,400 shares at about $3.03 ($22K), marked as a 10b5-1 plan trade. Holdings down 7% to 98,589 shares. | SEC filing Filed Jul 1, 2026 |
| Jun 25–26, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 11,156 shares between Jun 25 and Jun 26 at about $3.04 ($34K), marked as a 10b5-1 plan trade. Holdings down 10% to 105,989 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 22–23, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 11,444 shares between Jun 22 and Jun 23 at about $3.48 ($40K), marked as a 10b5-1 plan trade. Holdings down 9% to 117,145 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 16–17, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 4,126 shares between Jun 16 and Jun 17 at about $3.18 ($13K), marked as a 10b5-1 plan trade. Holdings down 3% to 128,589 shares. | SEC filing Filed Jun 18, 2026 |
| Jun 11–15, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 18,124 shares between Jun 11 and Jun 15 at about $3.88 ($70K), marked as a 10b5-1 plan trade. Holdings down 12% to 132,715 shares. | SEC filing Filed Jun 15, 2026 |
| Jun 8–10, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 22,385 shares between Jun 8 and Jun 10 at about $4.17 ($93K), marked as a 10b5-1 plan trade. Holdings down 13% to 150,839 shares. | SEC filing Filed Jun 10, 2026 |
| Jun 3–5, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 8,285 shares between Jun 3 and Jun 5 at about $4.37 ($36K), marked as a 10b5-1 plan trade. Holdings down 5% to 173,224 shares. | SEC filing Filed Jun 5, 2026 |
| May 29–Jun 2, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 652 shares between May 29 and Jun 2 at about $4.72 ($3K), marked as a 10b5-1 plan trade. Holdings down <1% to 181,509 shares. | SEC filing Filed Jun 2, 2026 |
| May 11–28, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 12,763 shares between May 11 and May 28 at about $5.44 ($69K), marked as a 10b5-1 plan trade. Holdings down 7% to 182,161 shares. | SEC filing Filed May 29, 2026 |
| May 22, 2026 | Planned (10b5-1) | Quang X Pham (CEO and Director) sold 1,165 shares at about $5.69 ($7K), marked as a 10b5-1 plan trade. Holdings down 1% to 194,924 shares. | SEC filing Filed May 26, 2026 |
| Dec 29, 2025 | Planned (10b5-1) | Matthew K Szot (CFO) sold 9,933 shares at about $6.97 ($69K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 31, 2025 |
6 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CVKD in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.